Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Silméia Garcia Zanati-Basan
Spironolactone Is Secure and Reduces Left Ventricular Hypertrophy in Hemodialysis Patients
Therapeutic Advances in Cardiovascular Disease
Cardiovascular Medicine
Pharmacology
Cardiology
Related publications
159 Allopurinol Reduces Left Ventricular Mass in Patients With Type 2 Diabetes and Left Ventricular Hypertrophy
Heart
Cardiovascular Medicine
Cardiology
Out-Of-Hemodialysis-Unit Blood Pressure Is a Superior Determinant of Left Ventricular Hypertrophy
Hypertension
Internal Medicine
Left Ventricular Relaxation in Patients With Left Ventricular Hypertrophy Secondary to Aortic Valve Disease
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Unexplained Left Ventricular Hypertrophy
Clinical pharmacology and therapy
Electrocardiographic Signs of Left Ventricular Hypertrophy and Strain in Hypertensive Patients
Heart
Cardiovascular Medicine
Cardiology
Update on Left Ventricular Hypertrophy
Kardiovaskulare Medizin
Cardiovascular Medicine
Cardiology
Risk Factors for Left Ventricular Dysfunction in Chronic Hemodialysis Patients.
Nihon Toseki Igakkai Zasshi
Multidirectional Myocardial Systolic Function in Hemodialysis Patients With Preserved Left Ventricular Ejection Fraction and Different Left Ventricular Geometry
Nephrology Dialysis Transplantation
Medicine
Transplantation
Nephrology
Candesartan Cilexetil Improves Left Ventricular Function, Left Ventricular Hypertrophy, and Endothelial Function in Patients With Hypertensive Heart Disease
Circulation Journal
Medicine
Cardiovascular Medicine
Cardiology